THE KOREA REGENERATIVE MEDICINE GUIDE
Evidence
Blinding and placebo effects
Expectations and measurement can influence results, particularly when symptoms fluctuate.
“Use this guide to frame clear, indication-specific questions for your specialist consultation.”
PATIENT EVIDENCE & CONSULTATION GUIDE
Category: Evidence · Editorial Review: Updated 20 October 2026 · 3 minute read
What blinding does
Blinding means that certain people involved in a study do not know which intervention a participant received. Depending on the design, this can include participants, treating staff, or outcome assessors. It helps reduce the influence of expectations on reporting, care, and measurement. Not every procedure can be blinded easily, so the study should explain how it addresses potential bias.
Improvement can have several causes
Symptoms may improve because of the treatment, ordinary fluctuation, additional care, expectation, or regression toward a more typical level after a bad period. A patient can experience real improvement without the experimental product being its cause. This is one reason an uncontrolled before-and-after comparison is weaker evidence than a carefully designed comparative study.
Objective does not mean perfect
Imaging, laboratory tests, and physical performance measures can provide useful information, but their interpretation can also be influenced by measurement methods or assessor knowledge. Blinded assessment can be valuable even when the patient knows the treatment. Ask how outcomes were collected and whether the people rating them knew which intervention was given.
How to read a success story
A testimonial communicates one person’s experience but cannot show how often improvement occurs or what would have happened without treatment. Look for comparative results and clear outcome definitions. This approach respects patient experiences while avoiding the assumption that every positive story demonstrates a causal treatment effect.
Continue exploring
- Preclinical research: before a treatment reaches people
- Clinical endpoints: what counts as improvement
- Surrogate markers and biological age claims
- Prepare your consultation checklist
Sources & further reading
Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.
CONTINUE YOUR PREPARATION
Prepare for your clinical conversation.
Combine the questions in this guide with our 12-point consultation checklist or explore Seoul clinic profiles.
CELLARIUM
Knowledge before possibility.
Cellarium is an independent editorial guide to regenerative medicine and stem cell consultations in South Korea. It does not provide medical advice, diagnosis, or treatment, and is not affiliated with any clinic or hospital.
© 2026 Cellarium — The Korea Regenerative Medicine Guide. Educational reference only; always consult a qualified specialist.